脆弱的X关联震/无氧综合征用多目标深度大脑刺激治疗
Francois Okoroafor1, Harriet Beattie2, Zekai Qiang2
1Neurosurgery Department, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK frankieokoroafor@aol.com.
BMJ case reports
|May 27, 2024
概括
深度大脑刺激 (DBS) 有效地治疗了一名40多岁的男性,患有脆弱X关联震/缺氧综合征 (FXTAS). 多目标DBS提供了优秀的长期抑制,为管理这种罕见的神经退行性疾病提供了希望.
科学领域:
- 神经学 神经学
- 神经退行性疾病 神经退行性疾病
- 运动障碍 运动障碍
背景情况:
- 脆弱的X关联/缺氧综合征 (FXTAS) 是一种渐进的遗传性神经退行性疾病.
- 它的特点是意图震和小脑动,通常影响老龄化人口.
研究的目的:
- 报告使用深度大脑刺激 (DBS) 治疗FXTAS的成功病例.
- 评估多目标DBS在管理FXTAS症状中的长期疗效.
主要方法:
- 一名中年男性患者有震病史,通过基因检测和MRI诊断出FXTAS.
- 患者接受了腹腔中间核和腹腔后核的双边多目标DBS.
- 使用神经生理学引导的DBS编程.
主要成果:
- 在9年的随访中,患者经历了优秀的神经功能和抑制.
- 核磁共振扫描显示了中小脑脚中特有的高T2信号,支持了FXTAS诊断.
结论:
- 多目标DBS是为选定的FXTAS患者提供可行和有效的长期治疗选择.
- 神经生理学引导的编程增强了DBS在FXTAS中抑制震的有效性.
更多相关视频
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
8.9K
10:58TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism
Published on: December 28, 2010
17.0K
相关概念视频
Alzheimer's Disease: Treatment
180
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
180
Parkinson's Disease: Treatment
261
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
261
